The Effect of Osteopathic Visceral Manipulation on Pain, Mobility and Functional Disability in Patients With Right Shoulder Adhesive Capsulitis
2026年7月14日 更新者：Bilinç Doğruöz Karatekin、Istanbul Medeniyet University
The aim of this study was to evaluate the effects of adding osteopathic visceral manipulation (OVM) to a standard physical therapy program on pain, functional disability, and range of motion (ROM) in patients diagnosed with right shoulder adhesive capsulitis (AC).
A total of 49 patients aged between 40 and 65 years who were diagnosed with right shoulder AC were included in the study.
Randomized patients received a standard physical therapy program for three weeks, consisting of 15 sessions (5 days per week) in both treatment groups.
The standard program included hot pack application to the shoulder region for 20 min, conventional transcutaneous electrical nerve stimulation (TENS) for 20 min, and ultrasound therapy at 1.5 W/cm² for 10 min.
In addition to the standard physical therapy program, Group 1 (n=25) received OVM once weekly, while Group 2 (n=24) received sham OVM once weekly.
Pain was evaluated using the Visual Analog Scale (VAS), while functional disability was evaluated using the Shoulder Pain and Disability Index (SPDI).
The ROM values were also recorded.
研究概览
研究类型
介入性
注册 (实际的)
56
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习地点
-
-
-
Istanbul、土耳其（türkiye）
- Goztepe Suleyman Yalcin Sehir Hastanesi Fiziksel Tıp ve Rehabilitasyon Klinigi
-
-
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
不
描述
Inclusion Criteria:
- Age between 18 and 65 years
- Presence of pain originating from the right shoulder region persisting for at least 6 weeks
- Availability of two-view shoulder radiographs obtained prior to the study to exclude causes of shoulder pain other than AC
- No local corticosteroid injection for shoulder pain within the previous 6 months
- No physical therapy administered for shoulder pain within the previous 6 months
- No use of non-steroidal anti-inflammatory drugs (NSAIDs) during the study period
Availability of laboratory assessments including:
- Complete blood count (CBC)
- Erythrocyte sedimentation rate (ESR)
- Liver function tests (AST, ALT)
- C-reactive protein (CRP)
- Pain intensity score of at least 4 cm on the Visual Analog Scale (VAS, 0-10 cm)
Exclusion Criteria:
- History of shoulder fracture on the affected side
- Prior shoulder surgery
- History of traumatic shoulder instability (subluxation or dislocation)
- History of shoulder or visceral organ surgery within the past 6 months
- History of systemic or inflammatory disease or malignancy
- Presence of metabolic or endocrine bone disease
- Pregnancy
- Neurological disorders affecting upper extremity function
- Psychiatric disorders that could interfere with treatment compliance or symptom evaluation
- Use of antiplatelet medication
- Previous osteopathic treatment
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Group 1 (OVM group, n=28) received a standard physical therapy program
|
In the OVM group, mobilization of the liver and diaphragm was performed.
Liver mobilization was applied in three planes (coronal, transverse, and sagittal) for 5 min each, totaling 15 min, while the diaphragm technique was applied for 2 min.
|
|
假比较器：Group 2 (Sham group, n=28) received the same standard physical therapy program
|
In the sham OVM group, light pressure and touch were applied with the palm over the same points selected for OVM, without the intention of providing therapeutic effect.
|
研究衡量的是什么？
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Pain (VAS)
大体时间：From enrollment to the end of treatment at 4 weeks
|
From enrollment to the end of treatment at 4 weeks
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Active shoulder ROM for abduction, flexion, internal rotation, and external rotation
大体时间：From enrollment to the end of treatment at 4 weeks
|
From enrollment to the end of treatment at 4 weeks
|
|
Shoulder Pain and Disability Index (SPADI)
大体时间：From enrollment to the end of treatment at 4 weeks
|
From enrollment to the end of treatment at 4 weeks
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2023年1月10日
初级完成 (实际的)
2024年5月15日
研究完成 (实际的)
2025年3月20日
研究注册日期
首次提交
2026年7月6日
首先提交符合 QC 标准的
2026年7月14日
首次发布 (实际的)
2026年7月15日
研究记录更新
最后更新发布 (实际的)
2026年7月15日
上次提交的符合 QC 标准的更新
2026年7月14日
最后验证
2026年7月1日
更多信息
与本研究相关的术语
其他研究编号
- 2022/0670
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.